CLINICAL RESEARCH: HEART FAILURE
Admission B-Type Natriuretic Peptide Levels and In-Hospital Mortality in Acute Decompensated Heart Failure
Gregg C. Fonarow, MD, FACC*,*,
William F. Peacock, MD ,
Christopher O. Phillips, MD, MPH ,
Michael M. Givertz, MD, FACC ,
Margarita Lopatin, MS|| for the ADHERE Scientific Advisory Committee and Investigators
* Ahmanson–UCLA Cardiomyopathy Center, University of California, Los Angeles Medical Center, Los Angeles, California
Department of Emergency Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio
Department of Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio
Department of Medicine, Brigham & Women’s Hospital, Boston, Massachusetts
|| Department of Biostatistics, Scios Inc., Mountain View, California.
Manuscript received November 20, 2006;
revised manuscript received January 3, 2007,
accepted February 5, 2007.
* Reprint requests and correspondence: Dr. Gregg C. Fonarow, University of California, Los Angeles, Division of Cardiology, 10833 Le Conte Avenue, Los Angeles, California 90095. (Email: gfonarow{at}mednet.ucla.edu).
Objectives: This study was designed to determine whether admission B-type natriuretic peptide (BNP) levels are predictive of in-hospital mortality in acute decompensated heart failure (HF).
Background: Levels of BNP have been demonstrated to facilitate the diagnosis of HF and predict mortality in chronic systolic HF.
Methods: B-type natriuretic peptide levels within 24 h of presentation were obtained in 48,629 (63%) of 77,467 hospitalization episodes entered in ADHERE (Acute Decompensated Heart Failure National Registry). In-hospital mortality was assessed by BNP quartiles in the entire cohort and in patients with reduced (n = 19,544) as well as preserved (n = 18,164) left ventricular systolic function using chi-square and logistic regression models.
Results: Quartiles (Q) of BNP were Q1 (<430), Q2 (430 to 839), Q3 (840 to 1,729), and Q4 ( 1,730 pg/ml). The BNP levels were <100 pg/ml in 3.3% of the total cohort. Patients in Q1 versus Q4 were younger, more likely to be women, and had lower creatinine and higher left ventricular ejection fraction. There was a near-linear relationship between BNP quartiles and in-hospital mortality: Q1 (1.9%), Q2 (2.8%), Q3 (3.8%), and Q4 (6.0%), p < 0.0001. B-type natriuretic peptide quartile remained highly predictive of mortality even after adjustment for age, gender, systolic blood pressure, blood urea nitrogen, creatinine, sodium, pulse, and dyspnea at rest, Q4 versus Q1 (adjusted odds ratio 2.23 [95% confidence interval 1.91 to 2.62, p < 0.0001]). The BNP quartiles independently predicted mortality in patients with reduced and preserved systolic function.
Conclusions: An elevated admission BNP level is a significant predictor of in-hospital mortality in acute decompensated HF with either reduced or preserved systolic function, independent of other clinical and laboratory variables. (Registry for Acute Decompensated Heart Failure Patients; http://www.clinicaltrials.gov/show/NCT00366639; NCT00366639
[ClinicalTrials.gov]
).
|
Abbreviations and Acronyms
| | BMI = body mass index | | BNP = B-type natriuretic peptide | | BUN = blood urea nitrogen | | HF = heart failure | | LV = left ventricular | | LVEF = left ventricular ejection fraction | | NT-proBNP = N-terminal pro-B-type natriuretic peptide | | Q = quartile |
|
This article has been cited by other articles:
|
|
|
|
 
G. C. M. Linssen, M. Rienstra, T. Jaarsma, A. A. Voors, I. C. van Gelder, H. L. Hillege, and D. J. van Veldhuisen
Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction
Eur J Heart Fail,
October 1, 2011;
13(10):
1111 - 1120.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. S. Wessler, D. G. Kramer, J. L. Kelly, T. A. Trikalinos, D. M. Kent, M. A. Konstam, and J. E. Udelson
Drug and Device Effects on Peak Oxygen Consumption, 6-Minute Walk Distance, and Natriuretic Peptides as Predictors of Therapeutic Effects on Mortality in Patients With Heart Failure and Reduced Ejection Fraction
Circ Heart Fail,
September 1, 2011;
4(5):
578 - 588.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. S. Anand, T. S. Rector, J. G. Cleland, M. Kuskowski, R. S. McKelvie, H. Persson, J. J. McMurray, M. R. Zile, M. Komajda, B. M. Massie, et al.
Prognostic Value of Baseline Plasma Amino-Terminal Pro-Brain Natriuretic Peptide and Its Interactions With Irbesartan Treatment Effects in Patients With Heart Failure and Preserved Ejection Fraction: Findings From the I-PRESERVE Trial
Circ Heart Fail,
September 1, 2011;
4(5):
569 - 577.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. D. Kociol, J. R. Horton, G. C. Fonarow, E. M. Reyes, L. K. Shaw, C. M. O'Connor, G. M. Felker, and A. F. Hernandez
Admission, Discharge, or Change in B-Type Natriuretic Peptide and Long-Term Outcomes: Data From Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF) Linked to Medicare Claims
Circ Heart Fail,
September 1, 2011;
4(5):
628 - 636.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Metra, C. M. O'Connor, B. A. Davison, J. G. F. Cleland, P. Ponikowski, J. R. Teerlink, A. A. Voors, M. M. Givertz, G. A. Mansoor, D. M. Bloomfield, et al.
Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT Study
Eur. Heart J.,
June 2, 2011;
32(12):
1519 - 1534.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. A. Lurati Buse, M. T. Koller, C. Burkhart, M. D. Seeberger, and M. Filipovic
The Predictive Value of Preoperative Natriuretic Peptide Concentrations in Adults Undergoing Surgery: A Systematic Review and Meta-Analysis
Anesth. Analg.,
May 1, 2011;
112(5):
1019 - 1033.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Thygesen, J. Mair, C. Mueller, K. Huber, M. Weber, M. Plebani, Y. Hasin, L. M. Biasucci, E. Giannitsis, B. Lindahl, et al.
Recommendations for the use of natriuretic peptides in acute cardiac care: A position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care
Eur. Heart J.,
February 2, 2011;
(2011)
ehq509v1.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. K. Singh, M. F. Cocchiaro, and M. D. Kittleson
NT-proBNP measurement fails to reliably identify subclinical hypertrophic cardiomyopathy in Maine Coon cats
Journal of Feline Medicine and Surgery,
December 1, 2010;
12(12):
942 - 947.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. L. Weintraub, S. P. Collins, P. S. Pang, P. D. Levy, A. S. Anderson, C. Arslanian-Engoren, W. B. Gibler, J. K. McCord, M. B. Parshall, G. S. Francis, et al.
Acute Heart Failure Syndromes: Emergency Department Presentation, Treatment, and Disposition: Current Approaches and Future Aims: A Scientific Statement From the American Heart Association
Circulation,
November 9, 2010;
122(19):
1975 - 1996.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Metra, J. R. Teerlink, G. M. Felker, B. H. Greenberg, G. Filippatos, P. Ponikowski, S. L. Teichman, E. Unemori, A. A. Voors, B. D. Weatherley, et al.
Dyspnoea and worsening heart failure in patients with acute heart failure: results from the Pre-RELAX-AHF study
Eur J Heart Fail,
October 1, 2010;
12(10):
1130 - 1139.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Nunez, J. Sanchis, V. Bodi, G. C. Fonarow, E. Nunez, V. Bertomeu-Gonzalez, G. Minana, L. Consuegra, M. J. Bosch, A. Carratala, et al.
Improvement in risk stratification with the combination of the tumour marker antigen carbohydrate 125 and brain natriuretic peptide in patients with acute heart failure
Eur. Heart J.,
July 2, 2010;
31(14):
1752 - 1763.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Metra, J. G. Cleland, B. Davison Weatherley, H. C. Dittrich, M. M. Givertz, B. M. Massie, C. M. O'Connor, P. Ponikowski, J. R. Teerlink, A. A. Voors, et al.
Dyspnoea in patients with acute heart failure: an analysis of its clinical course, determinants, and relationship to 60-day outcomes in the PROTECT pilot study
Eur J Heart Fail,
May 1, 2010;
12(5):
499 - 507.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Uthoff, C. Thalhammer, M. Potocki, T. Reichlin, M. Noveanu, M. Aschwanden, D. Staub, N. Arenja, T. Socrates, R. Twerenbold, et al.
Central venous pressure at emergency room presentation predicts cardiac rehospitalization in patients with decompensated heart failure
Eur J Heart Fail,
May 1, 2010;
12(5):
469 - 476.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Gheorghiade, F. Follath, P. Ponikowski, J. H. Barsuk, J. E. A. Blair, J. G. Cleland, K. Dickstein, M. H. Drazner, G. C. Fonarow, T. Jaarsma, et al.
Assessing and grading congestion in acute heart failure: a scientific statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine
Eur J Heart Fail,
May 1, 2010;
12(5):
423 - 433.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. M. Dunlay, M. Gheorghiade, K. J. Reid, L. A. Allen, P. S. Chan, P. J. Hauptman, F. Zannad, A. P. Maggioni, K. Swedberg, M. A. Konstam, et al.
Critical elements of clinical follow-up after hospital discharge for heart failure: insights from the EVEREST trial
Eur J Heart Fail,
April 1, 2010;
12(4):
367 - 374.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. I. Chaudhry, Y. Wang, T. M. Gill, and H. M. Krumholz
Geriatric Conditions and Subsequent Mortality in Older Patients With Heart Failure
J. Am. Coll. Cardiol.,
January 26, 2010;
55(4):
309 - 316.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Holme, A. H. Aastveit, N. Hammar, I. Jungner, and G. Walldius
Lipoprotein components and risk of congestive heart failure in 84 740 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)
Eur J Heart Fail,
November 1, 2009;
11(11):
1036 - 1042.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. M. Dunlay, Y. Gerber, S. A. Weston, J. M. Killian, M. M. Redfield, and V. L. Roger
Prognostic Value of Biomarkers in Heart Failure: Application of Novel Methods in the Community
Circ Heart Fail,
September 1, 2009;
2(5):
393 - 400.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. V. Shah, A. A. Chen-Tournoux, M. H. Picard, R. R.J. van Kimmenade, and J. L. Januzzi
Serum Levels of the Interleukin-1 Receptor Family Member ST2, Cardiac Structure and Function, and Long-Term Mortality in Patients With Acute Dyspnea
Circ Heart Fail,
July 1, 2009;
2(4):
311 - 319.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. J. Singer, R. H. Birkhahn, D. Guss, A. Chandra, C. D. Miller, B. Tiffany, P. Levy, R. Dunne, A. Bastani, H. C. Thode Jr, et al.
Rapid Emergency Department Heart Failure Outpatients Trial (REDHOT II): A Randomized Controlled Trial of the Effect of Serial B-Type Natriuretic Peptide Testing on Patient Management
Circ Heart Fail,
July 1, 2009;
2(4):
287 - 293.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S Dhar, G S Pressman, S Subramanian, S Kaul, S Gollamudi, E J Bloom, and V M Figueredo
Natriuretic peptides and heart failure in the patient with chronic kidney disease: a review of current evidence
Postgrad. Med. J.,
June 1, 2009;
85(1004):
299 - 302.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. L. Pina and C. O'Connor
BNP-Guided Therapy for Heart Failure
JAMA,
January 28, 2009;
301(4):
432 - 434.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. E.A. Blair, F. Zannad, M. A. Konstam, T. Cook, B. Traver, J. C. Burnett Jr, L. Grinfeld, H. Krasa, A. P. Maggioni, C. Orlandi, et al.
Continental Differences in Clinical Characteristics, Management, and Outcomes in Patients Hospitalized With Worsening Heart Failure: Results From the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) Program
J. Am. Coll. Cardiol.,
November 11, 2008;
52(20):
1640 - 1648.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Maisel, C. Mueller, K. Adams Jr., S. D. Anker, N. Aspromonte, J. G.F. Cleland, A. Cohen-Solal, U. Dahlstrom, A. DeMaria, S. Di Somma, et al.
State of the art: Using natriuretic peptide levels in clinical practice
Eur J Heart Fail,
September 1, 2008;
10(9):
824 - 839.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. S. Maisel, W. F. Peacock, N. McMullin, R. Jessie, G. C. Fonarow, J. Wynne, and R. M. Mills
Timing of Immunoreactive B-Type Natriuretic Peptide Levels and Treatment Delay in Acute Decompensated Heart Failure: An ADHERE (Acute Decompensated Heart Failure National Registry) Analysis
J. Am. Coll. Cardiol.,
August 12, 2008;
52(7):
534 - 540.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. B. Daniels, G. A. Laughlin, P. Clopton, A. S. Maisel, and E. Barrett-Connor
Minimally Elevated Cardiac Troponin T and Elevated N-Terminal Pro-B-Type Natriuretic Peptide Predict Mortality in Older Adults: Results From the Rancho Bernardo Study
J. Am. Coll. Cardiol.,
August 5, 2008;
52(6):
450 - 459.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A L Baggish, D M Lloyd-Jones, J Blatt, A M Richards, J Lainchbury, M O'Donoghue, R Sakhuja, A A Chen, and J L Januzzi
A clinical and biochemical score for mortality prediction in patients with acute dyspnoea: derivation, validation and incorporation into a bedside programme
Heart,
August 1, 2008;
94(8):
1032 - 1037.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Nishii, T. Inomata, H. Takehana, T. Naruke, T. Yanagisawa, M. Moriguchi, S. Takeda, and T. Izumi
Prognostic Utility of B-Type Natriuretic Peptide Assessment in Stable Low-Risk Outpatients With Nonischemic Cardiomyopathy After Decompensated Heart Failure
J. Am. Coll. Cardiol.,
June 17, 2008;
51(24):
2329 - 2335.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. M. Mills
Learning to Use a Biomarker: More About B-Type Natriuretic Peptide
J. Am. Coll. Cardiol.,
June 17, 2008;
51(24):
2336 - 2338.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. P. Dal-Bianco, A. S. Jaffe, M. R. Bell, and J. K. Oh
Cardiac Function and Brain-Type Natriuretic Peptide in First-Time Flash Pulmonary Edema
Mayo Clin. Proc.,
March 1, 2008;
83(3):
289 - 296.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. B. Daniels and A. S. Maisel
Natriuretic Peptides
J. Am. Coll. Cardiol.,
December 18, 2007;
50(25):
2357 - 2368.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W.H. W. Tang and G. S. Francis
The Year in Heart Failure
J. Am. Coll. Cardiol.,
December 11, 2007;
50(24):
2344 - 2351.
[Full Text]
[PDF]
|
|
|
|
|
|
|
BNP Level Predicts Mortality in Acute Decompensated Heart Failure
Journal Watch Emergency Medicine,
June 1, 2007;
2007(601):
1 - 1.
[Full Text]
|
|
|
|
